InvestorsHub Logo
Followers 37
Posts 2699
Boards Moderated 0
Alias Born 01/09/2019

Re: None

Tuesday, 04/23/2019 11:07:24 AM

Tuesday, April 23, 2019 11:07:24 AM

Post# of 163972
Here are some statements I found intresting beyond bedding..

1) During 2017 and 2018 Vystar contracted with two consultants and manufacturers to make exam and surgical gloves on an OEM basis. The testing and results were encouraging and led to further efforts prepare for a potential launch of these lines in 2019. The company is going to proceed with testing and subsequent filing with the USFDA to obtain 510(k) allowances. With this new OEM structure, the Company will bring several versions (surgical, exam, household, etc) of the gloves to market under its own OEM brand label.

2) UV Flu’s product line includes:



? RXair™ Residential Filterless Air Purifier
? UV400 ™ FDA cleared Class II Filterless Air Purifier
? RX3000™ Commercial FDA cleared Class II Air Purifier (news video with RX3000)


Vystar acquired all UV Flu intellectual property, multiple patents, product lines, tooling, FDA clearances, research data, websites and other assets related to the business.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYST News